Cargando…

Myelotoxicity of Temozolomide Treatment in Patients with Glioblastoma Is It Time for a More Mechanistic Approach?

Detalles Bibliográficos
Autores principales: Said, Medhat M., Broen, Martinus P. G., Swart, Eleonora L., Bartelink, Imke H., Kouwenhoven, Mathilde C. M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10000921/
https://www.ncbi.nlm.nih.gov/pubmed/36900352
http://dx.doi.org/10.3390/cancers15051561
_version_ 1784904003389227008
author Said, Medhat M.
Broen, Martinus P. G.
Swart, Eleonora L.
Bartelink, Imke H.
Kouwenhoven, Mathilde C. M.
author_facet Said, Medhat M.
Broen, Martinus P. G.
Swart, Eleonora L.
Bartelink, Imke H.
Kouwenhoven, Mathilde C. M.
author_sort Said, Medhat M.
collection PubMed
description
format Online
Article
Text
id pubmed-10000921
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-100009212023-03-11 Myelotoxicity of Temozolomide Treatment in Patients with Glioblastoma Is It Time for a More Mechanistic Approach? Said, Medhat M. Broen, Martinus P. G. Swart, Eleonora L. Bartelink, Imke H. Kouwenhoven, Mathilde C. M. Cancers (Basel) Editorial MDPI 2023-03-02 /pmc/articles/PMC10000921/ /pubmed/36900352 http://dx.doi.org/10.3390/cancers15051561 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Editorial
Said, Medhat M.
Broen, Martinus P. G.
Swart, Eleonora L.
Bartelink, Imke H.
Kouwenhoven, Mathilde C. M.
Myelotoxicity of Temozolomide Treatment in Patients with Glioblastoma Is It Time for a More Mechanistic Approach?
title Myelotoxicity of Temozolomide Treatment in Patients with Glioblastoma Is It Time for a More Mechanistic Approach?
title_full Myelotoxicity of Temozolomide Treatment in Patients with Glioblastoma Is It Time for a More Mechanistic Approach?
title_fullStr Myelotoxicity of Temozolomide Treatment in Patients with Glioblastoma Is It Time for a More Mechanistic Approach?
title_full_unstemmed Myelotoxicity of Temozolomide Treatment in Patients with Glioblastoma Is It Time for a More Mechanistic Approach?
title_short Myelotoxicity of Temozolomide Treatment in Patients with Glioblastoma Is It Time for a More Mechanistic Approach?
title_sort myelotoxicity of temozolomide treatment in patients with glioblastoma is it time for a more mechanistic approach?
topic Editorial
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10000921/
https://www.ncbi.nlm.nih.gov/pubmed/36900352
http://dx.doi.org/10.3390/cancers15051561
work_keys_str_mv AT saidmedhatm myelotoxicityoftemozolomidetreatmentinpatientswithglioblastomaisittimeforamoremechanisticapproach
AT broenmartinuspg myelotoxicityoftemozolomidetreatmentinpatientswithglioblastomaisittimeforamoremechanisticapproach
AT swarteleonoral myelotoxicityoftemozolomidetreatmentinpatientswithglioblastomaisittimeforamoremechanisticapproach
AT bartelinkimkeh myelotoxicityoftemozolomidetreatmentinpatientswithglioblastomaisittimeforamoremechanisticapproach
AT kouwenhovenmathildecm myelotoxicityoftemozolomidetreatmentinpatientswithglioblastomaisittimeforamoremechanisticapproach